Stay updated on FG-3019 in Diabetic Kidney Disease Clinical Trial
Sign up to get notified when there's something new on the FG-3019 in Diabetic Kidney Disease Clinical Trial page.

Latest updates to the FG-3019 in Diabetic Kidney Disease Clinical Trial page
- Check6 days agoChange DetectedLocations were expanded to include state-by-state listings for Arizona, California, Georgia, Illinois, Kansas, Louisiana, Massachusetts, Michigan, Nebraska, New Jersey, New York, North Carolina, Ohio, Tennessee, Texas, Virginia, and Washington. The page also now shows Revision: v3.3.3, replacing v3.3.2.SummaryDifference2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2. Core study details and page layout remain unchanged.SummaryDifference0.0%

- Check35 days agoChange DetectedA minor site revision label was added (v3.3.1) and the previous revision reference (v3.2.0) was removed. No study content or protocol details were changed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedNotice about government funding and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check56 days agoChange DetectedNo significant changes detected between the old and new screenshots of the Study Details page for NCT00913393. The content and layout appear consistent with the previous version.SummaryDifference0.3%

- Check85 days agoChange DetectedUpgrade to v3.2.0 with a new government-operating status notice and funding caveat; removes v3.1.0. This introduces current-operational caveats and directs users to status pages.SummaryDifference5%

Stay in the know with updates to FG-3019 in Diabetic Kidney Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 in Diabetic Kidney Disease Clinical Trial page.